je.st
news
Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial
2013-02-14 14:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. The Company Records $493 Million Charge Reducing 2012 GAAP Results WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, announced today that it has reached an agreement in principle with plaintiffs to resolve two federal securities class-action lawsuits. The suits are pending in the U.S. District Court for the District of New Jersey against Merck, Schering-Plough Corporation and certain of their current and former officers and directors. Language: English Contact HTML: MerckMedia Contacts:Ron Rogers, 908-423-6449Steve Cragle, 908-423-3461ORInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: related
trial
enhance
securities
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|
|||